about
Interferon Beta for Primary Progressive Multiple SclerosisInterferon Beta for Primary Progressive Multiple SclerosisPaediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities onlyInterferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosisThe immunopathology of multiple sclerosis: an overviewNatural history of primary progressive multiple sclerosisIssues and practices in multiple sclerosis.Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques.Multiple sclerosis lesions: insights from imaging techniques.Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation.Microwave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.The pathology of primary progressive multiple sclerosis.Axonal damage in multiple sclerosis.The double-edged sword of autoimmunity: lessons from multiple sclerosis.Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.Clinical characteristics of progressive relapsing multiple sclerosis.An integrated approach to design novel therapeutic interventions for demyelinating disordersGlatiramer acetate in multiple sclerosis.The relation between menarche and the age of first symptoms in a multiple sclerosis cohort.Mechanisms regulating regional localization of inflammation during CNS autoimmunity.Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot studyFemale-specific issues in multiple sclerosis.The X-Linked Hypothesis of Brain Disorders: Can Gender Ratios Tell Us Anything About Cellular Etiology of Neurodegenerative and Psychiatric Diseases?Clinical scales in progressive MS: predicting long-term disability.Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria.Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.T2 hypointense rims and ring-enhancing lesions in MS.
P2860
Q24240620-45F545BE-7203-4294-8501-E28AFE7241B8Q24241541-11C625D1-D7E7-4AE0-9820-B3DC5A842322Q26748229-9D5C2672-891D-4F20-8B6F-C8DF1F909001Q26799233-FABC8130-C7A9-4C74-B888-A7882A18FF73Q28265516-66F7C701-954A-4188-9D0C-958C9EBC7885Q28272201-A57ACF39-4AD1-46AA-B25F-C8A3A20A950FQ28295115-9CE84902-669A-45C3-A196-A15A2D5ECB0FQ29391465-B447276A-46A4-4441-8582-4696E7EC0500Q30751454-6462AD1E-D728-46D8-A332-735C9434351AQ30928115-19C71AC8-5FCD-4C96-9683-EA06A6FC878CQ30940046-5CCE0956-60D1-4709-869F-9431A75CE2C9Q33505423-B9ADBC36-5C34-44A9-A10F-37103D9A4D82Q34078026-5AAD8099-15F4-404A-A9AF-BCE7F7A0E63FQ34124465-E6547694-4BE4-43F7-A43F-51376868C1AFQ34295012-ED457666-7D95-43C7-9E78-04EDE9F9E993Q34301521-369B4CBF-5822-44A4-A733-CCE8D8362CD9Q34625041-D874F67A-842A-4E3B-A27B-0A6D06511B16Q35126104-5129BACB-C73A-43A5-B3BC-51C430BE1538Q35155753-1CB23721-C5BD-42D8-9704-3052F6A4DA68Q35818129-9A4A91C7-E45A-424A-AFEE-E2DDB97C4077Q35870214-E0A7E81E-C23F-4FED-B65F-114C44A58CA5Q36059972-B3DD83CE-6DEF-4960-B154-49AD1E0C6DE3Q36198583-07935053-C167-4B3A-A2DC-405C5ECF1E1DQ36501521-5F8E0358-B477-4384-A261-E5EC5E23DC93Q36918129-118F1529-42AD-4015-B710-F75A6A5DC9AAQ37107063-89683197-AC8D-4636-80F4-C08F07737FE7Q37174067-62E607FA-EAAF-4132-83AB-8773CB2FA460Q38238242-9C298F2F-0B1E-495F-9067-4F5206EEF486Q39714188-3D3522B0-ECC0-4555-BBBB-801C878A0165Q40920098-11A31F9E-434F-4E51-A66D-8E38D5156662Q41349564-3D8E349A-B8CF-45A3-B340-5FE04035CB91Q44922355-4B83F4E8-D8AA-4BFF-BBAE-FB9D728609F2Q44981816-161A46D0-C54A-4EB2-83BF-F413772EDCE7Q45051419-60A79244-F425-4110-B8B4-5875E990C1B4Q46548047-3C65F6A1-AB65-4081-ADBA-E44C460C6449Q46889094-05478B80-BB67-4430-80C1-4DE86CF43D5AQ47237680-0B701F52-3C06-4229-8F58-BC915793C034Q47758798-B7A3A4FA-6E0D-40AE-9431-88E8DDB3C021Q47931219-35505953-2A9B-4AF9-A743-7DD72304A4B1Q48100322-CA9CE5DD-0D32-4689-96EF-54F02A3CDF4C
P2860
description
im Juni 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1997
@uk
name
Primary progressive multiple sclerosis
@en
Primary progressive multiple sclerosis
@nl
type
label
Primary progressive multiple sclerosis
@en
Primary progressive multiple sclerosis
@nl
prefLabel
Primary progressive multiple sclerosis
@en
Primary progressive multiple sclerosis
@nl
P2093
P356
P1433
P1476
Primary progressive multiple sclerosis
@en
P2093
A J Thompson
C H Polman
D H Miller
W I McDonald
P304
P356
10.1093/BRAIN/120.6.1085
P407
P478
120 ( Pt 6)
P577
1997-06-01T00:00:00Z